Europe Bone Grafts And Substitutes Market Size & Outlook
Europe bone grafts and substitutes market, 2017-2030 (US$M)
Related Markets
Europe bone grafts and substitutes market highlights
- The Europe bone grafts and substitutes market generated a revenue of USD 833.9 million in 2022.
- The market is expected to grow at a CAGR of 5.2% from 2023 to 2030.
- In terms of segment, allograft was the largest revenue generating material type in 2022.
- Synthetic is the most lucrative material type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2023 to 2030.
Europe data book summary
| Market revenue in 2022 | USD 833.9 million |
| Market revenue in 2030 | USD 1,250.9 million |
| Growth rate | 5.2% (CAGR from 2022 to 2030) |
| Largest segment | Allograft |
| Fastest growing segment | Synthetic |
| Historical data covered | 2017 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Allograft, Synthetic |
| Key market players worldwide | DePuy Synthes, Baxter International Inc, NuVasive, Smith & Nephew PLC, Medtronic PLC, Orthofix Medical Inc, Zimmer Biomet Holdings Inc, Geistlich Pharma, Stryker Corp, AlloSource, TBF, OST Laboratoires, Biobank |
Other key industry trends
- In terms of revenue, Europe region accounted for 29.7% of the global bone grafts and substitutes market in 2022.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 1,057.5 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Bone Grafts And Substitutes Market Scope
Bone Grafts And Substitutes Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Europe bone grafts and substitutes market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bone grafts and substitutes market will help companies and investors design strategic landscapes.
Allograft was the largest segment with a revenue share of 61.7% in 2022. Horizon Databook has segmented the Europe bone grafts and substitutes market based on allograft, synthetic covering the revenue growth of each sub-segment from 2017 to 2030.
Key countries in the European region include Germany, UK, & France. Relatively less stringent medical devices approval process in the region is primarily boosting the market. In addition, high disposable income, owing to presence of developed economies, and availability of well-established healthcare infrastructure & skilled professionals are some of the major factors propelling the growth of the market.
Reasons to subscribe to Europe bone grafts and substitutes market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Europe bone grafts and substitutes market databook
-
Our clientele includes a mix of bone grafts and substitutes market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe bone grafts and substitutes market , including forecasts for subscribers. This continent databook contains high-level insights into Europe bone grafts and substitutes market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Europe bone grafts and substitutes market size, by country, 2017-2030 (US$M)
Europe Bone Grafts And Substitutes Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
